跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ryzodeg Flextouch - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ryzodeg Flextouch
Approved
STANDARD
Ryzodeg Flextouch
Novo Nordisk Production SAS
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9de0912438b349f8
Company
Novo Nordisk Production SAS
Type
Standard
Approval Details
Approval Id
9de0912438b349f8
Drug Approval Philippines Name
Ryzodeg Flextouch
Product Name
Ryzodeg Flextouch
Registration Number
BR-1433
Brand Name
Ryzodeg Flextouch
Generic Name
Insulin Degludec + Insulin Aspart
Dosage Form
Solution for Injection (SC)
Dosage Strength
100 Units/mL (70% Insulin Degludec/30% Insulin Aspart)
Manufacturer
Novo Nordisk Production SAS
Importer
Novo Nordisk Pharmaceuticals (Philippines), Inc.
Distributor
Novo Nordisk Pharmaceuticals (Philippines), Inc.
Issuance Date
25 November 2022
Expiry Date
25 November 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9de0912438b349f8
Type
Standard
Back to Philippines FDA Approvals